Farmakogenetik og skraeddersyet medicinsk behandling
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Farmakogenetik og skraeddersyet medicinsk behandling. / Nielsen, Finn Cilius; Borregaard, Niels.
I: Ugeskrift for læger, Bind 171, Nr. 10, 2009, s. 790-4.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Farmakogenetik og skraeddersyet medicinsk behandling
AU - Nielsen, Finn Cilius
AU - Borregaard, Niels
N1 - Keywords: Antibodies, Monoclonal; Antineoplastic Agents; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Neoplasms; Pharmacogenetics; Piperazines; Protein Kinase Inhibitors; Pyrimidines
PY - 2009
Y1 - 2009
N2 - Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology. Udgivelsesdato: 2009-Mar-2
AB - Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology. Udgivelsesdato: 2009-Mar-2
M3 - Tidsskriftartikel
C2 - 19265602
VL - 171
SP - 790
EP - 794
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 10
ER -
ID: 17215571